EX-99.2 4 tm2015122d3_ex99-2.htm EXHIBIT 99.2

Exhibit 99.2

^{Template
for notification and public disclosure of transactions by persons discharging manage-rial responsibilities
and persons closely associated with them}

^1.^{Details
of the person discharging managerial responsibilities/person closely associated}

^{a) Name Adam
Steensberg}

^2.^{Reason
for the notification}

^{a) Position/status EVP,
Chief Medical and Development Officer in Zealand Pharma A/S}

^{b) Initial
notification/Amend- Initial notification}

^ment

^3.^{Details
of the issuer, emission allowance market participant, auction platform, auctioneer or auc-}

^{tion monitor}

^{a) Name Zealand
Pharma A/S, CVR-no. 20045078}

^{b) LEI1 549300ITBB1ULBL4CZ12}

^{4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been conducted}

^{a) Description
of the financial Shares}

^{instrument,
type of instru-}

^ment

^{Identification
code DK0060257814}

^{b) Nature
of the transaction Sale of shares}

^{c) Price(s)
and volume(s)}

^Price(s)^Volume(s)

^{DKK 216,3 96}

^{d) Aggregated
information}

^{- Aggregated
volume DKK 20.762,41}

^- Price

^{e) Date
of the transaction 02 April 2020}

^{f) Place
of the transaction Nasdaq Copenhagen A/S}